Value Attribution in the Decision to Use of Whole Body MRI for Early Cancer Diagnosis.
cancer screening
decision aids
diffusion whole body
magnetic resonance
preferences
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
28 May 2021
28 May 2021
Historique:
received:
15
03
2021
revised:
18
05
2021
accepted:
26
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
3
6
2021
Statut:
epublish
Résumé
This study aimed to identify the main factors that asymptomatic individuals considered when deciding to undergo self-referred Whole-body MRI (WB-MRI) for early cancer diagnosis and the subjective values attributed to each mentioned factor in a Decision tree analysis. Personal characteristics such as risk perception and personality were investigated as possible factors affecting value attribution. Seventy-four volunteers (mean age 56.4; male = 47) filled a simplified decision tree by expressing the expected factors and related subjective values associated with two screening options for early cancer diagnosis (standard procedures vs. WB-MRI+standard procedures) while waiting for a WB-MRI examination. Questionnaires on risk perception and personality traits were also administered. Expected factors were summarized in 5 clusters: diagnostic certainty, psychological well-being, safety, test validity and time/cost. Test validity and time/cost were evaluated as potential losses in both procedures. Diagnostic Certainty and safety were evaluated as losses in standard screening, and as an advantage when considering WB-MRI+standard screening. Forty-five percent of participants considered WB-MRI+standard screening as beneficial for their psychological well-being. Finally, personal absolute and comparative risk to get cancer was associated with a positive value attribution to WB-MRI (
Identifiants
pubmed: 34071199
pii: diagnostics11060972
doi: 10.3390/diagnostics11060972
pmc: PMC8227751
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Eur Urol. 2017 Jan;71(1):81-92
pubmed: 27317091
Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2167-73
pubmed: 17119042
Cancer Imaging. 2020 May 11;20(1):34
pubmed: 32393345
Risk Anal. 2007 Feb;27(1):171-85
pubmed: 17362408
J Behav Med. 2006 Feb;29(1):37-49
pubmed: 16470344
Med Sci Sports Exerc. 2003 Nov;35(11):1823-7
pubmed: 14600545
CA Cancer J Clin. 2007 May-Jun;57(3):147-67
pubmed: 17507441
Risk Anal. 2004 Oct;24(5):1349-67
pubmed: 15563300
Acta Psychol (Amst). 2003 May;113(1):67-81
pubmed: 12679044
Magn Reson Imaging Clin N Am. 2018 Nov;26(4):495-507
pubmed: 30316463
Eur Radiol. 2019 Jul;29(7):3889-3900
pubmed: 30937589
Addict Behav. 2020 Apr;103:106222
pubmed: 31838445
Cognition. 1993 Oct-Nov;49(1-2):37-66
pubmed: 8287674
Ecancermedicalscience. 2019 Mar 28;13:914
pubmed: 31123497
J Med Genet. 2020 Apr;57(4):226-236
pubmed: 31719169
Radiol Med. 2019 Mar;124(3):218-233
pubmed: 30430385
Prev Med. 2000 Dec;31(6):714-21
pubmed: 11133339
Crit Rev Oncol Hematol. 2016 Apr;100:69-73
pubmed: 26852078
Radiology. 2019 Apr;291(1):5-13
pubmed: 30806604
Br J Radiol. 2021 Feb 1;94(1118):20191031
pubmed: 33237810
BMC Public Health. 2012 Jan 25;12:80
pubmed: 22276600
Patient Prefer Adherence. 2015 Nov 23;9:1677-86
pubmed: 26648700
J Environ Public Health. 2009;2009:891754
pubmed: 20041018
Clin Imaging. 2018 Nov - Dec;52:246-251
pubmed: 30170274
Science. 1981 Jan 30;211(4481):453-8
pubmed: 7455683